2h
The Brighterside of News on MSNSurprising New Research Redefines Alcohol’s Effects on the Brain and AddictionAlcohol contributes to more than 200 health conditions, fueling a staggering 175,000 deaths each year across the U.S.
Two Kingston men plan to open a 102-bed drug-and-alcohol rehabilitation and mental health counseling center for adolescents ...
Dietitian-supported intensive nutritional therapy improves survival and disease severity in patients with alcohol-related acute-on-chronic liver failure, a study finds.
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
4d
PureWow on MSNOzempic and Alcohol: Can GLP-1s Cure Addiction? I Asked the ExpertsI’d have dismissed the report had I not spoken with a pal who has lost a solid 20-plus pounds using a GLP-1. “I believe it,” ...
Louisville Courier-Journal on MSN6dOpinion
I work with people battling addiction. Trump's tariffs won't stop fentanyl. | OpinionUsing tariffs to get other countries to solve our drug crisis is at best ineffective and at worst disingenuous.
The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...
Patients who receive inpatient treatment are far more likely to be prescribed life-saving addiction medications, a new study ...
Studies show promising results for semaglutide as a potential treatment for alcohol use disorder. Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment and weight loss.
The following is a summary of “A Randomized Clinical Trial of Prolonged Exposure Therapy With and Without Topiramate for Comorbid PTSD and Alcohol Use Disorder,” published in the March 2025 issue of ...
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results